Suppr超能文献

免疫功能低下重症监护病房患者的腹腔内感染和脓毒症:疾病表现、微生物病因学和临床结局。

Intra-abdominal infection and sepsis in immunocompromised intensive care unit patients: Disease expression, microbial aetiology, and clinical outcomes.

机构信息

Intensive Care Department, Centro Hospitalar Universitario S. Joao, Faculty of Medicine, University of Porto, Portugal; Grupo Infecao e Sepsis, Portugal.

Nimes University Hospital, University of Montpellier, Nimes, France; Ciberes and Vall d'Hebron Institute of Research, Barcelona, Spain.

出版信息

Eur J Intern Med. 2024 Nov;129:100-110. doi: 10.1016/j.ejim.2024.07.019. Epub 2024 Jul 29.

Abstract

We compared epidemiology of intra-abdominal infection (IAI) between immunocompromised and non-immunocompromised ICU patients and identified risk factors for mortality. We performed a secondary analysis on the "AbSeS" database, a prospective, observational study with IAI patients from 309 ICUs in 42 countries. Immunocompromised status was defined as either neutropenia or prolonged corticosteroids use, chemotherapy or radiotherapy in the past year, bone marrow or solid organ transplantation, congenital immunodeficiency, or immunosuppressive drugs use. Mortality was defined as ICU mortality at any time or 28-day mortality for those discharged earlier. Associations with mortality were assessed by logistic regression. The cohort included 2589 patients of which 239 immunocompromised (9.2 %), most with secondary peritonitis. Among immunocompromised patients, biliary tract infections were less frequent, typhlitis more frequent, and IAIs were more frequently healthcare-associated or early-onset hospital-acquired compared with immunocompetent patients. No difference existed in grade of anatomical disruption, disease severity, organ failure, pathogens, and resistance patterns. Septic shock was significantly more frequent in the immunocompromised population. Mortality was similar in both groups (31.1% vs. 28.9 %; p = 0.468). Immunocompromise was not a risk factor for mortality (OR 0.98, 95 % CI 0.66-1.43). Independent risk factors for mortality among immunocompromised patients included septic shock at presentation (OR 6.64, 95 % CI 1.27-55.72), and unsuccessful source control with persistent inflammation (OR 5.48, 95 % CI 2.29-12.57). In immunocompromised ICU patients with IAI, short-term mortality was similar to immunocompetent patients, despite the former presented more frequently with septic shock, and septic shock and persistent inflammation after source control were independent risk factors for death.

摘要

我们比较了免疫功能低下和非免疫功能低下 ICU 患者的腹腔内感染 (IAI) 流行病学,并确定了死亡率的危险因素。我们对“AbSeS”数据库进行了二次分析,该数据库是一项前瞻性、观察性研究,纳入了来自 42 个国家 309 个 ICU 的 IAI 患者。免疫功能低下状态定义为中性粒细胞减少症或过去一年中长时间使用皮质类固醇、化疗或放疗、骨髓或实体器官移植、先天性免疫缺陷或使用免疫抑制药物。死亡率定义为任何时候 ICU 死亡率或提前出院的 28 天死亡率。使用逻辑回归评估与死亡率的相关性。该队列包括 2589 名患者,其中 239 名免疫功能低下(9.2%),大多数为继发性腹膜炎。在免疫功能低下的患者中,胆道感染较少见,盲肠炎更常见,且与免疫功能正常的患者相比,IAI 更常见于医疗保健相关或早发性医院获得性感染。解剖结构破坏程度、疾病严重程度、器官衰竭、病原体和耐药模式无差异。免疫功能低下人群中脓毒症休克更为常见。两组死亡率相似(31.1%比 28.9%;p=0.468)。免疫功能低下不是死亡的危险因素(OR 0.98,95%CI 0.66-1.43)。免疫功能低下患者死亡的独立危险因素包括就诊时脓毒症休克(OR 6.64,95%CI 1.27-55.72)和持续炎症的源控制失败(OR 5.48,95%CI 2.29-12.57)。在免疫功能低下的 ICU 合并 IAI 的患者中,短期死亡率与免疫功能正常的患者相似,尽管前者更常出现脓毒症休克,而源控制后脓毒症休克和持续炎症是死亡的独立危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验